Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

• Published in: Child and adolescent psychiatry and mental health Vol. 11; no. 1; pp. 34 - 11
• Main Authors: Walker, Daniel J., DelBello, Melissa P., Landry, John, D’Souza, Deborah N., Detke, Holland C.
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.07.2017; BioMed Central; BMC
• Subjects: Adolescence; Adolescents; Affective disorders; Analysis; Antidepressants; Antipsychotics; Behavior; Bipolar; Bipolar disorder; Care and treatment; Child & adolescent psychiatry; Child health; Children; Children & youth; Childrens health; Clinical trials; Depression; Dosage and administration; Drug therapy; Emotions; Families & family life; Fluoxetine; Mental depression; Mental disorders; Mental health; Olanzapine; Olanzapine fluoxetine combination; Pediatrics; Psychological aspects; Psychotropic drugs; Quality of life; Quantitative psychology; Questionnaires; Schizophrenia; Teenagers; Well being; United States > US; Bipolar; Depression; Olanzapine fluoxetine combination; Children; Adolescents; Quality of life

We examined the efficacy of olanzapine/fluoxetine combination (OFC) in improving health-related quality of life (QoL) in the treatment of bipolar depression in children and adolescents. Patients aged 10-17 years with bipolar I disorder, depressed episode, baseline children's depression rating s...